Israeli entrepreneur Dr Yaron Daniely is running a nine-week Baker Institute Innovation Fellows program.
Daniely is a key player at global healthtech and life sciences investment fund, aMoon, and the program is aimed at entrepreneurship and commercialisation for early to mid-career scientists from the Baker Institute, Walter and Eliza Hall Institute and Murdoch Children’s Research Institute.
Daniely recently visited Australia, the trip being facilitated by major supporter of the Baker Heart and Diabetes Institute, Philip Munz.
Munz said, “Dr Yaron Daniely from aMoon brings a wealth of expertise which will support some of Australia’s brightest researchers to translate their science, deliver impact and foster healthier communities.”
The aMoon company works closely with global academic institutions to facilitate the translation of academic research into practical applications by providing guidance within innovation mentoring programs.
“The Baker Heart and Diabetes Institute has been collaborating with Israeli scientists for some years now, and has established important relationships with organisations including the Sheba Medical Centre, Hadassah Medical Centre and the Technion,” said Baker Institute director, Professor Tom Marwick.
He added, “The Baker Institute Innovation Fellows program, which we are now running in Melbourne in collaboration with our Israeli friends at aMoon, aims to further strengthen our entrepreneurship and commercialisation skills, and expand opportunities in this area both in Australia and Israel.
“We are very grateful to one of our major supporters, Mr Philip Munz AM, for facilitating this important visit,” he concluded.
The Baker Institute hosted a reception for Daniely in April to meet local business, political and scientific leaders.
Daniely told The AJN that he is “intrigued and excited” by the “density and depth of healthcare innovation that is taking place in Victoria”.
He added, “During my short trip here it became evident to me that innovative public-private partnership models could further the dramatic impact that local translational research may offer Australia and the world.”